Dr. Gray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 E Lancaster Ave
MOB East, Suite 356
Wynnewood, PA 19096Phone+1 484-476-2639Fax+1 484-476-9000
Summary
- William A. Gray, MD, serves as System Chief, Division of Cardiovascular Diseases at Main Line Health and Co-Director of Lankenau Heart Institute in Philadelphia, PA.
Dr. Gray’s clinical expertise includes the full range of catheter-based coronary, structural, and vascular diagnostic and therapeutic interventions, including repair of structural heart defects, mitral valve repair, left atrial appendage closure, aneurysm management, and head-to-toe arterial and venous interventions.
Dr. Gray has served in cardiovascular leadership roles for nearly 20 years. Prior to joining Main Line Health, he served as Director of Endovascular Services at New York-Presbyterian/Columbia University Medical Center and as Director of Endovascular Services at Swedish Medical Center in Seattle.
In addition to his leadership positions, Dr. Gray has been instrumental in growing the field of endovascular medicine through clinical training program development and oversight.
Dr. Gray has significant research experience and has served as principal investigator for more than 50 clinical trials of coronary, endovascular, and structural heart interventions. He often is called upon to consult on development of both device and protocol design for national multicenter clinical trials of experimental devices, which has led to his increasing role as national principal investigator.
Dr. Gray is a Fellow of the American College of Cardiology and a Fellow of The Society for Cardiac Angiography and Interventions. He has served on the editorial board of JACC: Cardiovascular Interventions and is a current editorial board member of Catheterization and Cardiovascular Interventions as well as a reviewer for several other peer-reviewed cardiovascular publications.
Education & Training
- Brown UniversityFellowship, Cardiovascular Disease, 1988 - 1992
- Brown UniversityResidency, Internal Medicine, 1984 - 1988
- Lewis Katz School of Medicine at Temple UniversityClass of 1984
Certifications & Licensure
- PA State Medical License 2016 - 2024
- NY State Medical License 2005 - 2017
- CT State Medical License 2007 - 2008
- WA State Medical License 1999 - 2006
- NM State Medical License 1992 - 2002
- RI State Medical License 1986 - 1993
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- CAPTURE 2 Post-Marketing Registry Start of enrollment: 2006 Mar 01
- Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) Start of enrollment: 2006 Nov 01
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Start of enrollment: 2011 Sep 16
Publications & Presentations
PubMed
- 32 citationsPercutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.Trevor Simard, Marino Labinaz, Firas Zahr, Babak Nazer, William A. Gray
JACC. Cardiovascular Interventions. 2020-05-25 - 634 citationsPercutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.Ted Feldman, Saibal Kar, Michael Rinaldi, Peter S. Fail, James B. Hermiller
Journal of the American College of Cardiology. 2009-08-18 - 19 citationsIntravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.Gunnar Tepe, Marianne Brodmann, William Bachinsky, Andrew Holden, Thomas Zeller
Journal of the Society for Cardiovascular Angiography & Interventions. 2022-05-19
Press Mentions
- It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?November 14th, 2024
- Contego Medical’s Neuroguard IEP System Approved by FDA for Carotid RevascularizationOctober 15th, 2024
- Radiaction Establishes Medical Advisory BoardAugust 13th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: